-+ 0.00%
-+ 0.00%
-+ 0.00%

TANGO THERAPEUTICS ANNOUNCES FIRST PATIENT DOSED IN TNG456 PHASE 1/2 TRIAL IN PATIENTS WITH MTAP-DELETED GLIOBLASTOMAS AND OTHER SOLID TUMORS

Reuters·05/21/2025 11:00:00

Please log in to view news